Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

2026March › 20

NHS

3 months ago

Revolutionary artificial intelligence glasses for dementia sufferers can 'see' objects and project prompts on to lenses to help them live independently.
Donanemab and lecanemab have been shown to delay progression from mild to moderate Alzheimer's by up to six months but are not currently available on NHS.
Ifenyinwa Chizube Ndulue-Nonso claimed to have experience working with a range of different health problems but her colleagues quickly discovered there were gaps in her knowledge.

page 1 of 1